Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.
Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...
Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.
Some common NGS platforms include Illumina (sequencing by synthesis), Ion Torrent (semiconductor sequencing), and Pacific Biosciences (single-molecule real-time sequencing). Third-generation ...
Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...
Roche, Illumina and Life Technologies ... such as pyrosequencing, sequencing by synthesis or sequencing by ligation. However, most platforms adhere to a common library preparation procedure ...
San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech ...
Meanwhile, it doesn't seem coincidental that Illumina, which is the most significant genetic sequencing business in the world, has a large Chinese rival in biotech BGI Genomics. Ever feel like you ...
Roche, Illumina and Life Technologies ... such as pyrosequencing, sequencing by synthesis or sequencing by ligation. However, most platforms adhere to a common library preparation procedure ...
Illumina's (ILMN) stock slid 5% post-market after it released its Q4 earnings report and reiterated its 2025 guidance, ...